The American Academy of Microbiology has elected Dr. Kyu Rhee, a professor of medicine in the Division of Infectious Diseases, to its Class of 2024. Fellows of the American Academy of Microbiology, an honorific leadership group within the American Society for Microbiology (ASM), are elected annually through a highly selective, peer-review process based on their records of scientific achievement and original contributions that have advanced microbiology.
Dr. Kyu Rhee
In recent years, Dr. Rhee has been broadly recgonized as a leading physician-scientist for his pioneering work in developing new tools to study the biochemistry of tuberculosis (TB), the leading cause of death from bacterial infection worldwide. Current TB chemotherapies are longer and more complex than for virtually any other bacterial infection. As a result, these once-therapeutic miracles have given way to rates of treatment non-compliance and failure sufficient to allow continued transmission and promote the paradoxical emergence of multidrug (MDR) and extensively drug resistant (XDR) disease. The Rhee Lab seeks to address both shortfalls by applying metabolomic technologies to elucidate the intracellular biochemistry of Mycobacterium tuberculosis (Mtb) and its response to perturbation by host relevant stresses and antimycobacterial compounds.
Dr. Rhee received his undergraduate degree from Cornell University and his M.D. and Ph.D. degrees from the University of California, Irvine, followed by clinical training in internal medicine and infectious diseases at Weill Cornell, where he has remained on the faculty since 2005.
Related Links
Dr. Kyu Rhee awarded $2.2 Million NIAID Grant to Launch Collaborative, Multi-Department Physician-Scientist Program
Dr. Kyu Rhee Inducted into Association of American Physicians